AI Model Can Differentiate Prefibrotic Primary Myelofibrosis From Essential Thrombocythemia With High Accuracy

The model may help clinicians identify patients who would benefit from disease-specific therapies or enrollment into clinical trials.

Related Keywords

Tampa ,Florida ,United States ,Italy ,American ,Leica Biosystems ,Andrew Srisuwananukorn ,Jamesm Dolezal ,Moffitt Srisuwananukorn ,International Consensus Classification Of Myeloid Neoplasms ,University Of Florence ,University Of Chicago ,American Society Of Hematology ,World Health Organization ,Ohio State University Comprehensive Cancer Center ,Division Of Hematology ,Moffitt Cancer Center ,Department Of Internal Medicine ,American Society ,Annual Meeting ,Internal Medicine ,Image Credit ,International Consensus Classification ,Myeloid Neoplasms ,Minerva High Performance Computer ,Mount Sinai ,